Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

An 8-year-old girl with vitiligo developed extra hair growth on her knee after using tacrolimus ointment.

This study identified a new variety of central centrifugal cicatricial alopecia that includes patchy hair loss on the lateral and posterior scalp in African-American women, which could be misdiagnosed as traction alopecia without dermatoscopy and pathology.

Glycerin in hand cream can cause allergic skin reactions.

This article discusses common dermatologic side effects of psychopharmacologic agents such as eruptions, urticaria, and photosensitivity, but it reports no new research findings.

This review discusses the role of hair microscopy in diagnosing alopecia, stating that while it excludes diagnoses related to hair breakage, it only confirms nonspecific short anagen in alopecia cases.

This study found that loose anagen syndrome was more common in females and observed across all hair colors and skin types.

This study found that diphencyprone showed a significant clinical response for treating alopecia areata, while tacrolimus was not effective.

Fox Fordyce disease might be more common in prepubertal girls than thought and can be managed with treatment.

This report details the clinical presentation and management of cutaneous mastocytosis in Indian children and provides no new experimental findings.

This study reported that Taiwanese pre-teens and teenagers with atopic diseases, such as food allergies and asthma, had a significantly increased risk of developing alopecia areata, with the risk being 9.66 times higher compared to their peers without atopic conditions.

This report describes a 6-year-old girl with Turner syndrome and coexisting psoriasis, alopecia areata, and trachyonychia, suggesting a potential link between these conditions.

This population-based study found a significant association between alopecia areata and autoimmune thyroid diseases, including Hashimoto's and Graves' disease, confirming a higher prevalence of these conditions in individuals with alopecia areata.

In this study, a 38-year-old male with syphilis-related mixed pattern alopecia showed marked hair regrowth and resolution of postauricular lymphadenopathy after treatment with benzathine penicillin, suggesting that lymph node and hair examinations, along with trichoscopy, can aid in the diagnosis of alopecia syphilitica.

This study found that alopecia areata can affect individuals across various ages but is predominantly observed in males aged 21-40, and may be linked to autoimmune diseases, thyroid issues, and inflammation.

This study found that platelet-rich plasma treatment increased hair density and reduced inflammation in patients with patchy alopecia areata, but not in a patient with alopecia universalis.

The document says that hookworms are treated with mebendazole and stress-related hair loss usually gets better in 6 months, while other hair loss types have specific treatments.

In this prospective study, 15 patients with patchy alopecia areata treated with intralesional methotrexate every two weeks showed a significant improvement in hair regrowth and reduction in lesion severity, with changes linked to decreased tissue levels of TNF-α.

This narrative review found a strong association between alopecia areata and autoimmune thyroid diseases, suggesting routine thyroid function and autoantibody screening could be beneficial for certain patients with extensive, recurrent, or early-onset alopecia areata.

This case report describes an 18-year-old female with alopecia areata who experienced hair regrowth within seven days following Prachana Vidhi treatment in an Ayurvedic setting, suggesting this approach may offer effective results for patchy hair loss.

The abstract does not provide any specific research findings or results, but rather serves as a promotional description for IP Innovative Publication Pvt Limited, highlighting their services and publication offerings in medical journals and related fields from Delhi, India.

This vodcast discusses various tools for assessing the severity of alopecia areata, emphasizing the importance of considering psychosocial impacts alongside physical symptoms.

This study reviewed various studies and concluded that Janus kinase inhibitors, particularly tofacitinib, seem to promote hair regrowth in about half of patients with alopecia areata, though expected class-specific adverse effects were observed.

This case study describes a 55-year-old Japanese male with Vogt-Koyanagi-Harada disease who experienced no hair regrowth but did have hair repigmentation after localized steroid injections, highlighting an unusual late-onset poliosis and alopecia, which has not been previously reported.

This study surveyed dermatologists in Greece and Italy and found significant variability and challenges in the diagnosis and treatment of alopecia areata, including limited use of severity scores and diverse treatment approaches, particularly for special site involvement and chronic cases.

In this case report, a 59-year-old woman experienced burning sensations and developed atrophic, hypopigmented, ivory papules and plaques on her palms and soles over three years, which worsened after walking for extended periods.

This review highlights the variability and unpredictability of alopecia areata, ranging from single scalp patches to total body hair loss, and notes the 2022 approval of the first AA-specific drug, baricitinib, potentially spurring new research into targeted treatments.

This study found that patients with alopecia areata had higher levels of ESR, CRP, and mean platelet volume compared to controls, and that these markers, along with the neutrophils to lymphocytes ratio, were associated with increased disease severity.

This source outlines the autoimmune condition alopecia areata, discussing its unclear etiology, the significant psychological impact despite not being life-threatening, and the challenging nature of its treatment, which varies greatly among individuals. The article summarizes disease pathogenesis, prevention, and treatment options.

This study suggests that the EULAR/ACR classification criteria for SLE may help predict organ damage, particularly in renal, cardiovascular, dermatological, and gonadal domains.

This case study describes a 29-year-old man who presented with a fever and a generalized maculopapular rash, alongside symptoms like hair loss and joint pain, leading to an investigation into whether his condition was a case of the "great masquerader.